Vaccine Acceptance and Effectiveness after Pandemic Era for Infectious Diseases Eradication

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 3204

Special Issue Editors


E-Mail Website
Guest Editor

E-Mail Website
Guest Editor
Department of Medicine, University Kore of Enna, 94100 Enna, Italy
Interests: vaccine effectiveness; vaccine efficacy; vaccine acceptance; knowledge; attitude and practice on vaccination; socio-cognitive models and vaccine acceptance; health belief model and vaccination; health action process approach and vaccine; protection motivation theory model and vaccination; influenza vaccine acceptance; HPV vaccine acceptance; rotavirus vaccine acceptance; DTP vaccine acceptance; anti-SARS-CoV-2 vaccine acceptance; vaccination acceptance in healthcare workers; vaccination acceptance in at risk people; vaccination acceptance in adolescent; vaccination acceptance in parents; active call interventions for vaccines; vaccination and serology response; vaccination and cellular-immunity mediated response; anti-SARS-CoV-2 and B memory response; anti-SARS-CoV-2 and T memory response
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Vaccinations have gained relevance among the general population due to the spread of the SARS-CoV2 pandemic. Indeed, the availability of anti-SARS CoV2 vaccines have enabled the reduction of severe outcomes, though a massive resource implementation is required to achieve this. On the other hand, vaccination for vaccine preventable diseases other than SARS CoV2 have seen reduced use from healthcare services, providing an opportunity for an outbreak with potential pandemic power. In this scenario, people gained more knowledge of vaccine preventable disease based on two opposite approaches: acceptance of other vaccines or a refusal of other vaccines due to an increase in vaccine hesitancy. 

This Special Issue aims to collect manuscript that approach vaccine acceptance, including the management of adverse reaction, co-administration, communication, healthcare-related sources of information, and serological and cell-mediated immunity for different target populations. Contributors worldwide are encouraged to share their knowledge of vaccine acceptance from different healthcare perspectives, such as vaccine policy, management, administration, cost-effectiveness analysis and real-world data.

Prof. Dr. Alessandra Casuccio
Dr. Vincenzo Restivo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccination acceptance
  • vaccine hesitancy
  • co-administration
  • adverse reaction
  • communication
  • vaccine effectiveness
  • vaccine counselling
  • social–cognitive models
  • immunological response
  • cost-effectiveness analysis

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1275 KiB  
Article
Lessons Learned from the COVID-19 Vaccination Campaigns in Veneto Region: Population Vaccination Centers as Support for the Traditional Outpatient Model
by Sandro Cinquetti, Anna De Polo, Vincenzo Marcotrigiano, Marica Battistin, Erica Bino, Giulia De Mattia, Jacopo Fagherazzi, Nahuel Fiorito, Mattia Manzi, Anna Voltolini, Martina Mognato and Christian Napoli
Vaccines 2023, 11(11), 1695; https://doi.org/10.3390/vaccines11111695 - 07 Nov 2023
Viewed by 1132
Abstract
The extraordinary vaccination campaigns of the COVID-19 pandemic era put organizational and operational systems to the test in numerous territorial contexts. In the Veneto region, the activation of population vaccination centers (CVPs) guaranteed the provision of vaccines to mountain areas. These centers, drive-in [...] Read more.
The extraordinary vaccination campaigns of the COVID-19 pandemic era put organizational and operational systems to the test in numerous territorial contexts. In the Veneto region, the activation of population vaccination centers (CVPs) guaranteed the provision of vaccines to mountain areas. These centers, drive-in and building-based, improved the efficiency of dose administration in relation to similar conditions where healthcare workers (HCWs) were routinely involved in clinics. Overall, a comparison of the two models investigated, with the same numbers of HCWs involved and the same opening hours for the vaccination sites, has shown that the CVPs are able to guarantee three times as many vaccines administered, compared with the traditional outpatient model. This study aims to provide a detailed analysis of the adopted organizational model, highlighting the best practices and improvements required to guarantee a timely and effective public health response, and evaluating the opportunities to deploy these innovative methods actively in a standard context. Full article
Show Figures

Figure 1

13 pages, 267 KiB  
Article
Factors Associated with Anti-SARS-CoV-2 Vaccine Acceptance among Pregnant Women: Data from Outpatient Women Experiencing High-Risk Pregnancy
by Marianna Maranto, Giuseppe Gullo, Alessandra Bruno, Giuseppa Minutolo, Gaspare Cucinella, Antonio Maiorana, Alessandra Casuccio and Vincenzo Restivo
Vaccines 2023, 11(2), 454; https://doi.org/10.3390/vaccines11020454 - 16 Feb 2023
Cited by 7 | Viewed by 1545
Abstract
Pregnant women are at higher risk of severe Coronavirus disease 2019 (COVID-19) complications than non-pregnant women. The initial exclusion of pregnant women from anti-SARS-CoV-2 vaccines clinical trials has caused a lack of conclusive data about safety and efficacy for this vulnerable population. This [...] Read more.
Pregnant women are at higher risk of severe Coronavirus disease 2019 (COVID-19) complications than non-pregnant women. The initial exclusion of pregnant women from anti-SARS-CoV-2 vaccines clinical trials has caused a lack of conclusive data about safety and efficacy for this vulnerable population. This cross-sectional study aims to define the factors related to vaccination adherence in a sample of women experiencing high-risk pregnancies. The recruited women completed a questionnaire based on the Health Belief Model. Data were analyzed to evaluate the associations between socio-demographic variables and vaccination acceptance through descriptive, univariate and multivariate logistic analyses. Among the 233 women enrolled, 65.2% (n = 152) declared that they would accept the anti-SARS-CoV-2 vaccine. Multivariate analysis showed that vaccination acceptance was associated with a high educational level (aOR = 4.52, p = 0.001), a low perception of barriers to vaccination (aOR = 1.58, p = 0.005) and the gynecologist’s advice (aOR = 3.18, p = 0.01). About a third of pregnant women are still hesitant about the anti-SARS-CoV-2 vaccine, probably because of the conflicting information received from media, friends, acquaintances and health institutions. Determining factors linked to vaccine hesitancy among pregnant women is useful for creating vaccination strategies that increase vaccination uptake. Full article
Back to TopTop